1.Cook, TM, Counsell, D, Wildsmith, JAW; on behalf of the Royal College of Anesthetists Third National Audit Project. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anesthetists. British Journal of Anesthesia 2009; 102: 179–190
4.CLASP (Collaborative Low dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
6.James, AH, Abel, DE, Braucazio, LR. Anticoagulants in pregnancy. Obstetrical and Gynecological Survey 2005; 61: 59–61.
7.Wysowski, DK, Talarico, L, Bacsanyi, J, Botstein, P. Spinal and epidural hematoma and low molecular weight heparin. New England Journal of Medicine 1998; 338: 1774–1775.
8.Scottish Intercollegiate Guidelines Network. Section 7: Spinal and epidural blocks; Section 9: Pregnancy and puerperium. In Prophylaxis of Venous Thromboembolism. Publication No. 62. Edinburgh: SIGN; 2002: 24–26; 30–35.
9.Horlocker, TT, Wedel, DJ, Benzon, H et al. Regional anesthesia in the anticoagulated patient: Defining the risks (The Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Regional Anesthesia and Pain Medicine 2003; 23: 172–197.
10.Stafford-Smith, M. Impaired hemostasis and regional anesthesia. Canadian Journal of Anesthesia 1996; 43: R129–R141.
12.Asghar, F, Bowman, P. A clinical approach to the management of thrombosis in obstetrics Part 2: diagnosis and management of venous thromboembolism. The Obstetrician and Gynecologist 2007; 9: 3–8.
13.Gelson, E, Johnson, M, Gatzoulis, M, Uebing, A. Cardiac disease in pregnancy Part 2: acquired heart disease. The Obstetrician and Gynecologist 2007; 9: 83–87.
14.Austin, SK, Lambert, J, Peebles, D, Cohen, H. Managing peri-delivery anticoagulation in women on therapeutic dose low molecular weight heparin: a role for unfractionated heparin? Journal of Thrombosis and Hemostasis 2007; 5 (Supp 1): P-S–622.
15.Akkad, A, Oppenheimer, C, Mushambi, M, Pavord, S. Intrapartum care for women on full anticoagulation. International Journal of Obstetric Anesthesia 2003; 12: 188–192.
16.Loo, CC, Dahlgren, G, Irestedt, L. Neurological complications of obstetric regional analgesia. International Journal of Obstetric Anesthesia 2000; 9: 99–124.
17.Bates, SM, Greer, IA, Pabinger, I, Sofer, S, Hirsh, J. Venous Thromboembolism, Thrombophilias, Anti-thrombotic therapy and Pregnancy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 844S–886S.
18.Harrop-Griffiths, et al. on behalf of the Association of Anesthetists of Great Britain and Ireland, Obstetric Anesthetists’ Association and Regional Anesthesia UK. Regional anesthesia and patients with abnormalities of coagulation. Anesthesia 2013; 68: 966–972.
19.Leonhardt, G, Gaul, C, Nietsch, HH et al. Thrombolytic therapy in pregnancy. Journal of Thrombosis and Thrombolysis 2006; 21: 271–276.
20.Ekbatani, A, Asaro, LR, Malinow, AM. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia. International Journal of Obstetric Anesthesia 2010; 19: 82–87.
21.Young, SK, Al-Mondhiry, HA, Vaida, SJ, Ambrose, A, Botti, JJ. Successful use of argatroban during the third trimester of pregnancy: case report and review of the literature. Pharmacotherapy 2008; 28: 1531–1536.
22.Tanimura, K, Ebina, Y, Sonoyama, A, et al. Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency. Journal of Obstetrics and Gynaecology Research 2012; 38: 749–752.
23.Huhle, G, Geberth, M, Hoffmann, U, Heene, DL, Harenberg, J. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin. Gynecologic and Obstetric Investigation 2000; 49: 67–69.
24.Tang, AW, Greer, I. A systematic review on the use of new anticoagulants in pregnancy. Obstetric Medicine 2013; 6: 64–71.
25.Ciurzyński, M, Jankowski, K, Pietrzak, B et al. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Medical Science Monitor 2011; 17: CS56–59.
26.Duhl, AJ, Paidas, MJ, Ural, SH et al. Pregnancy and Thrombosis Working Group. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology 2007; 197: 457.e1–21.
27.Cohen, H, Arachchillage, DR, Middeldorp, S, Beyer-Westendorf, J, Abdul-Kadir, R. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis 2016. doi: 10.1111/jth.13366
28.Macafee, B, Campbell, JP, Ashpole, K, et al. Reference ranges for thromboelastography (TEG®) and traditional coagulation tests in term parturients undergoing cesarean section. Anesthesia 2012: 67: 741–747.
29.Armstrong, S, Fernando, R, Ashpole, K, Simons, R, Columb, M. Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. International Journal of Obstetric Anesthesia 2011; 20: 293–298.
30.Beilin, Y, Arnold, I, Hossain, S. Evaluation of the platelet function analyser (PFA-100®) vs. the thromboelastogram (TEG) in the parturient. International Journal of Obstetric Anesthesia 2006; 15(1): 7–12.